CD4 and neoplasm: Higher expression of CD4, CD25/IL2ra and Lag3 in EμMyc/Casp2−/− tumors, are indicative of activated regulatory T-cells (Tregs) at the tumor site, which are associated with both favorable and unfavorable prognosis in B-cell lymphomas64.